Search All News
The new $10 million Columbia-Pfizer Clinical Trials Diversity Initiative will aim to reduce health disparities by increasing the participation of underrepresented minorities in clinical trials.
New clinical trial studies the application of focused ultrasound technique to deliver chemotherapy in patients with DIPG, an aggressive type of brain cancer.
Results of a new phase 2 clinical trial demonstrate the potential of targeted therapy in combination with chemotherapy to treat patients with uterine leiomyosarcoma.
A novel drug combination is showing early promise for an entirely new, bladder-saving treatment option for patients.
- November 13, 2020
November marks Pancreatic Cancer Awareness month, and in this in-depth Q+A, Dr. Gulam Manji takes us through the exciting advances in pancreatic cancer treatment and research.
- May 4, 2020
Dr. Matthew Dallos and colleagues have opened the first clinical trial testing an anti-IL-8 compound as a potential therapy against COVID-19.
- February 24, 2020
A new clinical trial for AL amyloidosis is paving the way for a promising new treatment option for patients with the rare organ-debilitating disease.